BNP Paribas Financial Markets’s Janux Therapeutics JANX Stock Holding History

BNP Paribas Financial Markets’s Portfolio JANX Stock Details JANX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.46M	Buy	105,300 +101,349	+2,565%	+$1.39M	﹤0.01%	2869
2025 Q4	$54.5K	Sell	3,951 -9,924	-72%	-$233K	﹤0.01%	4642
2025 Q3	$339K	Buy	13,875 +6,202	+81%	+$151K	﹤0.01%	3759
2025 Q2	$177K	Buy	7,673 +4,982	+185%	+$131K	﹤0.01%	3817
2025 Q1	$72.7K	Sell	2,691 -4,137	-61%	-$156K	﹤0.01%	4156
2024 Q4	$366K	Buy	+6,828	New	+$361K	﹤0.01%	3492
2022 Q4	–	Sell	-7,638	Closed	-$103K	–	4329
2022 Q3	$103K	Buy	+7,638	New	+$102K	﹤0.01%	3755

Other funds holding JANX

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BNP Paribas Financial Markets's JANX Position: Q1 2026 in Review

BNP Paribas Financial Markets increased its Janux Therapeutics (JANX) stake by 2,565% in Q1 2026, buying an estimated $1.39M and bringing the position to 105,300 shares worth $1.46M. The position accounts for ﹤0.01% of the portfolio, ranked #2869.

BNP Paribas Financial Markets first reported a position in JANX in Q3 2022 and has held it in 7 quarters since. 190 funds tracked by Wall St. Rank hold JANX as of Q1 2026.

BNP Paribas Financial Markets held 105,300 shares of Janux Therapeutics worth $1.46M as of Q1 2026.
BNP Paribas Financial Markets bought 101,349 Janux Therapeutics shares in Q1 2026, an estimated $1.39M.
Janux Therapeutics made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #2869 holding.
BNP Paribas Financial Markets first reported a position in Janux Therapeutics in Q3 2022 and has held it in 7 quarters since.
190 funds tracked by Wall St. Rank held Janux Therapeutics as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.